Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873677 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
A Phase 3 study, sponsored by Maruho North America.
- Completed
- Registry status
- Phase 3
- Development phase
- 537
- Enrollment target
NCT01873677: Completed Phase 3 study, sponsored by Maruho North America.
NCT01873677 is a Phase 3 study that has completed, run by Maruho North America. The registered enrollment target is 537 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873677, a Phase 3 study, has completed, sponsored by Maruho North America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 537 participants
- Enrollment target
Study Summary
This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis.
Interventions
- DRUG Vehicle
- DRUG M518101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 537 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
What the finished NCT01873677 record still lists
NCT01873677 is an interventional study that assigns participants to a tested intervention. The registered 537 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01873677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01873677 about?
NCT01873677 is a clinical study titled "Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis". This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis.
What is the current status of trial NCT01873677?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 537 participants. The study started on 2013-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01873677?
The interventions under investigation include: Vehicle (DRUG), M518101 (DRUG).
Who is sponsoring clinical trial NCT01873677?
This trial is sponsored by Maruho North America, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01873677's enrollment target sits among peer trials
537 701st of 2000 higher than 1,299 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05880004 · 537 participants · NA
Developing a Support Application for Food Pantries (SAFPAS) to Improve Client Access to Healthy Foods & Enhance Emergency Preparedness
- NCT03772028 · 538 participants · Phase 3
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- NCT06538038 · 538 participants
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia